Used in research as a mitochondria-targeting compound due to the lipophilic triphenylphosphonium cation, which facilitates accumulation inside mitochondria. The structure includes a linker region with a hydroxy-methoxy benzoyl group, suggesting potential use in prodrug design or as a carrier for bioactive molecules into mitochondrial compartments. Commonly applied in studies involving oxidative stress, mitochondrial dysfunction, and cellular energy metabolism. Also explored in anticancer and neurodegenerative disease research for delivering therapeutic agents directly to mitochondria.